Vasoactive substances and fibrosing syndromes.
D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D008784:Methysergide / Q000009:adverse effects*; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D051381:Rats; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced* / Q000503:physiopathology; D012189:Retrospective Studies; D012701:Serotonin / Q000502:physiology*
D012701:Serotonin; D008784:Methysergide